里瓦罗克萨班 预防乳腺癌患者外围插入的中央导管相关血栓的预防方法
Die Sang1, Shiyu Li2, Shanmin Fan2
1Department of Medical Oncology, Beijing Chaoyang District Sanhuan Cancer Hospital, Beijing, China; Department of Medical Oncology, The Second Hospital of Dalian Medical University, Liaoning, China.
Archives of medical research
|June 8, 2025
概括
里瓦罗克萨班预防可显著降低带导管相关血栓 (CRT) 在乳腺癌患者与外围插入的中央导管 (PICC). 这种安全的,为期两个月的治疗有效地预防化疗期间的CRT.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 接受化疗的乳腺癌患者通常需要外围插入的中央导管 (PICC).
- 导管相关血栓塞 (CRT) 是与这些患者使用PICC相关的重大并发症.
- 预防CRT对于维持治疗连续性和患者安全至关重要.
研究的目的:
- 评估利瓦罗克萨班在通过PICC接受化疗的乳腺癌患者中预防CRT的疗效和安全性.
- 为了比较接受里瓦洛克萨班预防的患者和接受标准护理的患者之间的CRT发病率.
主要方法:
- 一项前性队列研究,涉及314名患有PICC的乳腺癌患者.
- 治疗组每天服用10毫克口服里瓦罗克萨班,持续2个月,再加上握力训练.
- 对照组仅接受了握力训练. 通过血管超声波诊断出CRT.
主要成果:
- 与对照组 (12.0%) 相比,里瓦洛克萨班组 (2.2%) 的CRT发病率明显较低 (p <0.001).
- 里瓦罗克萨班预防和50岁以上的年龄被确定为独立的抗CRT保护因素.
- 治疗是安全的,在CRT诊断的患者中没有报告新的血栓形成或肺栓塞.
结论:
- 两个月的里瓦罗克萨班预防有效地减少了乳腺癌患者的CRT发病率.
- 里瓦罗克萨班在这个患者群体中显示出预防CRT的良好的安全性.
- 用里瓦洛克萨班进行预防性抗凝血治疗可以成为管理PICC并发症的有价值策略.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
01:30Venous Thrombosis IV: Nursing Management
202
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
202
01:26Peripheral Artery Disease IV: Nursing Management
351
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
351
01:23Peripheral Artery Disease V: Postoperative Nursing Management
379
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
379
01:27Pulmonary Embolism III: Nursing Management
369
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
369
01:26Cardiac Catheterization IV: Nursing Management
661
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
661